Synthesis of selective A3 and M1 receptor agonists

Detailed within this thesis is the synthesis of three A1 agonists which were designed by Muscagen using computational studies. The agonists are derived from condensation of the modified adenosine: (4S,6R)-6-(6-chloro-9H-purin-9-yl)-N,2,2-trimethyltetrahydrofuro[3,4-d][1,3]dioxole-4-carboxamide with...

Full description

Bibliographic Details
Main Author: Snee, Stephen
Other Authors: Thomas, Jim
Published: University of Manchester 2011
Subjects:
547
Online Access:http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.686707
id ndltd-bl.uk-oai-ethos.bl.uk-686707
record_format oai_dc
spelling ndltd-bl.uk-oai-ethos.bl.uk-6867072017-10-04T03:17:58ZSynthesis of selective A3 and M1 receptor agonistsSnee, StephenThomas, Jim2011Detailed within this thesis is the synthesis of three A1 agonists which were designed by Muscagen using computational studies. The agonists are derived from condensation of the modified adenosine: (4S,6R)-6-(6-chloro-9H-purin-9-yl)-N,2,2-trimethyltetrahydrofuro[3,4-d][1,3]dioxole-4-carboxamide with novel heterocyclic primary amines. The amines 5-(aminomethyl)-N,N-diethyl-7-methyloxazolo[4,5-b]pyridin-2-amine, 5-(1-aminoethyl)-N,N,7-trimethyloxazolo[4,5-b]pyridin-2-amine and 5-(1-aminoethyl)-N,N-diethyl-7-methyloxazolo[4,5-b]pyridin-2-amine were prepared from 2-amino-6-((tert-butyldiphenylsilyloxy)methyl)-4-methylpyridin-3-ol which was available from 2,4-lutidine. The dimethylaminooxazole functionality was introduced by treating a 1,2-hydroxyaminopyridine with phosgene iminium chloride whereas the diethylamino-oxazoles were prepared by displacement of chloride from a 2-chloro-oxazole with diethylamine. Using chemistry developed by Ellman it was possible to introduce a methyl appendage into the scaffold. Also detailed within this thesis is the synthesis of the novel M1 agonist; (+/-) (3aS,7R,7aR)-3-benzyl-7-(furan-2-yl)hexahydrooxazolo[4,5-c]pyridin-2(3H)-one. Cyclobutanecarboxylic acid was elaborated to tert-butyl(4-cyanato-2-cyclobutylbut-2-enyloxy)dimethylsilane which underwent a [3,3]-sigmatropic rearrangement to afford tert-butyl(2-cyclobutyl-2-isocyanatobut-3-enyloxy)dimethyl silane which was treated with sodium benzalkoxide. This yielded the Cbz protected amine with the required quaternary centre installed. Ozonolysis of the olefin moiety gave an aldehyde to which (1-(furan-2-yl)vinyl)lithium was introduced with excellent diastereoselectivity. The resulting alkoxide underwent in situ cyclisation to form the oxazolidinone with concurrent loss of benzyl alcohol. Hydroboration was used to install the stereochemistry of the furan bearing carbon and the resulting alcohol was subjected to an intramolecular Fukuyama-Mitsunobu reaction to furnish the piperidine ring.547University of Manchesterhttp://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.686707https://www.research.manchester.ac.uk/portal/en/theses/synthesis-of-selective-a3-and-m1-receptor-agonists(aeb94780-f03b-4cb5-8a1a-86c85d00c5d0).htmlElectronic Thesis or Dissertation
collection NDLTD
sources NDLTD
topic 547
spellingShingle 547
Snee, Stephen
Synthesis of selective A3 and M1 receptor agonists
description Detailed within this thesis is the synthesis of three A1 agonists which were designed by Muscagen using computational studies. The agonists are derived from condensation of the modified adenosine: (4S,6R)-6-(6-chloro-9H-purin-9-yl)-N,2,2-trimethyltetrahydrofuro[3,4-d][1,3]dioxole-4-carboxamide with novel heterocyclic primary amines. The amines 5-(aminomethyl)-N,N-diethyl-7-methyloxazolo[4,5-b]pyridin-2-amine, 5-(1-aminoethyl)-N,N,7-trimethyloxazolo[4,5-b]pyridin-2-amine and 5-(1-aminoethyl)-N,N-diethyl-7-methyloxazolo[4,5-b]pyridin-2-amine were prepared from 2-amino-6-((tert-butyldiphenylsilyloxy)methyl)-4-methylpyridin-3-ol which was available from 2,4-lutidine. The dimethylaminooxazole functionality was introduced by treating a 1,2-hydroxyaminopyridine with phosgene iminium chloride whereas the diethylamino-oxazoles were prepared by displacement of chloride from a 2-chloro-oxazole with diethylamine. Using chemistry developed by Ellman it was possible to introduce a methyl appendage into the scaffold. Also detailed within this thesis is the synthesis of the novel M1 agonist; (+/-) (3aS,7R,7aR)-3-benzyl-7-(furan-2-yl)hexahydrooxazolo[4,5-c]pyridin-2(3H)-one. Cyclobutanecarboxylic acid was elaborated to tert-butyl(4-cyanato-2-cyclobutylbut-2-enyloxy)dimethylsilane which underwent a [3,3]-sigmatropic rearrangement to afford tert-butyl(2-cyclobutyl-2-isocyanatobut-3-enyloxy)dimethyl silane which was treated with sodium benzalkoxide. This yielded the Cbz protected amine with the required quaternary centre installed. Ozonolysis of the olefin moiety gave an aldehyde to which (1-(furan-2-yl)vinyl)lithium was introduced with excellent diastereoselectivity. The resulting alkoxide underwent in situ cyclisation to form the oxazolidinone with concurrent loss of benzyl alcohol. Hydroboration was used to install the stereochemistry of the furan bearing carbon and the resulting alcohol was subjected to an intramolecular Fukuyama-Mitsunobu reaction to furnish the piperidine ring.
author2 Thomas, Jim
author_facet Thomas, Jim
Snee, Stephen
author Snee, Stephen
author_sort Snee, Stephen
title Synthesis of selective A3 and M1 receptor agonists
title_short Synthesis of selective A3 and M1 receptor agonists
title_full Synthesis of selective A3 and M1 receptor agonists
title_fullStr Synthesis of selective A3 and M1 receptor agonists
title_full_unstemmed Synthesis of selective A3 and M1 receptor agonists
title_sort synthesis of selective a3 and m1 receptor agonists
publisher University of Manchester
publishDate 2011
url http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.686707
work_keys_str_mv AT sneestephen synthesisofselectivea3andm1receptoragonists
_version_ 1718542847409389568